Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

12.76 +0.16 (+1.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
20 21 Next >
News headline image
Recap: Viatris Q3 Earnings ↗
 
Via Benzinga
News headline image
3 Large-Cap Stocks to Buy Trading Below Book Value ↗
There aren’t too many large-cap stocks in the S&P 500 trading below book value. But here are three possibilities. 
Via InvestorPlace
Topics Stocks
News headline image
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors? ↗
Viatris now faces a narrower path to commercializing a generic copy of Ozempic. 
Via The Motley Fool
News headline image
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy? ↗
There's a chance shareholders won't notice any difference. 
Via The Motley Fool
News headline image
2 Healthcare Dividend Stocks You'd Regret Not Buying on the Dip ↗
These stocks may not be for everyone, but income-seekers might find what they're looking for in them. 
Via The Motley Fool
News headline image
Obesity Drug Wegovy's Triumph to Catapult Novo Holdings In Golden Era Of Wealth Boost ↗
Novo Holdings, the controlling shareholder of Novo Nordisk A/S (NYSE: NVO), is bracing for a significant influx of capital stemming from the thriving success of the weight-loss drug Wegovy.  
Via Benzinga
News headline image
Viatris Stock: Bear vs. Bull ↗
This is a case where both sides have compelling arguments. 
Via The Motley Fool
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris ↗
Via The Motley Fool
News headline image
Where Will Viatris Be in 5 Years? ↗
Can this become a good growth business to invest in? 
Via The Motley Fool
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
2 Top Value Stocks to Buy in October ↗
These two blue chip stocks offer top-notch yields, attractive valuations, and solid long-term prospects. 
Via The Motley Fool
News headline image
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Novo Nordisk Weight Loss Drug Patent Battle Against Viatris - Emerges As Winner ↗
Novo Nordisk A/S (NYSE: NVO) successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs,  
Via Benzinga
Topics Intellectual Property
News headline image
Viatris Stock Bounds Higher As Divestitures Reach Nearly $7 Billion ↗
The company is retaining the rights to specific over-the-counter drugs in some markets. 
Via Investor's Business Daily
News headline image
Viatris Phase 1 Asset Divestiture Story: Plans To Sell Certain OTC Products, Women's Healthcare Business & More ↗
Viatris Inc (NASDAQ: VTRS) disclosed multiple deals to sell remaining assets to conclude Phase 1 of planned asset disposition by  
Via Benzinga
News headline image
2 Beaten-Down Dividend Stocks to Buy ↗
These two stocks look like bargains right now for income investors. 
Via The Motley Fool
News headline image
Is Viatris Stock Good for Dividend Income? ↗
If you keep your expectations in check, it could be a great pick. 
Via The Motley Fool
News headline image
Could Viatris Stock Help You Become a Millionaire? ↗
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment? 
Via The Motley Fool
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to... 
Via Benzinga
News headline image
NASDAQ: VTRS Shareholder Notice Investigation over Potential Wrongdoing by Certain Directors of Viatris Inc. ↗
San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Viatris Inc.are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
News headline image
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase ↗
The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7." 
Via Benzinga
News headline image
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks ↗
These stocks offer some mouth-watering payouts. 
Via The Motley Fool
News headline image
3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗
Viatris, GSK, and Organon are all trading at less than 7 times earnings. 
Via The Motley Fool
News headline image
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know ↗
CVS just fired a shot across Viatris' bow. 
Via The Motley Fool
News headline image
VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy? ↗
There are a few complicating factors that mean the generic form of the drug might not be a slam dunk. 
Via The Motley Fool
News headline image
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today ↗
Would you have been better off investing in the S&P 500? 
Via The Motley Fool
Topics Stocks
News headline image
Viatris Q2 Earnings Beat Estimates, Multiple Sclerosis Therapy Accepted For FDA Review ↗
Viatris Inc (NASDAQ: VTRS) reported Q2 FY23 sales of $3.91 billion, up 2% on a divestiture-adjusted operational basis, marginally higher the  
Via Benzinga
News headline image
Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.